The Gross Margin of Coherus BioSciences Inc (CHRS) is 55.97%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 55.97% |
| 2023-12-31 | 38.19% |
| 2022-12-31 | 66.82% |
| 2021-12-31 | 82.36% |
| 2020-12-31 | 92.10% |
| 2019-12-31 | 95.20% |